OLLA, STEFANIA
OLLA, STEFANIA
Istituto di Ricerca Genetica e Biomedica - IRGB
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes
2023 Stefania Olla ; Chiara Siguri ; Antonella Fais ; Benedetta Era ; Massimo Claudio Fantini ; Amalia Di Petrillo
Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes
2023 Colombo, Eleonora; Olla, Stefania; Minnelli, Cristina; Formato, Alessia; Veroni, Caterina; Corbisiero, Silvia; Pericolo, Mattia; Siguri, Chiara; Mobbili, Giovanna; Agresti, Cristina; Seneci, Pierfausto
Combining human genetics of multiple sclerosis with oxidative stress phenotype for drug repositioning
2021 Olla, Stefania; Steri, Maristella; Formato, Alessia; Whalen, Michael B.; Corbisiero, Silvia; Agresti, Cristina
A Sardinian founder mutation in glycoprotein Ib platelet subunit beta(GP1BB) that impacts thrombocytopenia
2020 Busonero, Fabio; Steri, Maristella; Orru, Valeria; Sole, Gabriella; Olla, Stefania; Marongiu, Michele; Maschio, Andrea; Sidore, Carlo; Lai, Sandra; Mulas, Antonella; Zoledziewska, Magdalena; Floris, Matteo; Pala, Mauro; Forabosco, Paola; Asunis, Isadora; Pitzalis, Maristella; Deidda, Francesca; Masala, Marco; Caria, Cristian Antonio; Barella, Susanna; Abecasis, Goncalo R.; Schlessinger, David; Sanna, Serena; Fiorillo, Edoardo; Cucca, Francesco
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy
2020 Orrù, V; Steri, M; Sidore, C; Marongiu, M; Serra, V; Olla, S; Sole, G; Lai, S; Dei, M; Mulas, A; Virdis, F; Piras, Mg; Lobina, M; Marongiu, M; Pitzalis, M; Deidda, F; Loizedda, A; Onano, S; Zoledziewska, M; Sawcer, S; Devoto, M; Gorospe, M; Abecasis, Gr; Floris, M; Pala, M; Schlessinger, D; Fiorillo, E; Cucca, F
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone
2020 Agresti, Cristina; Mechelli, Rosella; Olla, Stefania; Veroni, Caterina; Eleuteri, Cecilia; Ristori, Giovanni; Salvetti, Marco
Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP
2019 Angius, Andrea; Uva, Paolo; Oppo, Manuela; Persico, Ivana; Onano, Stefano; Olla, Stefania; Pes, Valentina; Perria, Chiara; Cuccuru, Gianmauro; Atzeni, Rossano; Serra, Gigliola; Cucca, Francesco; Sotgiu, Stefano; Hennekam Raoul, C; Crisponi, Laura
Genetic-Driven Druggable Target Identification and Validation
2018 Floris, Matteo; Olla, Stefania; Schlessinger, David; Cucca, Francesco
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
2017 Eleuteri C.; Olla S.; Veroni C.; Umeton R.; Mechelli R.; Romano S.; Buscarinu M.C.; Ferrari F.; Calo G.; Ristori G.; Salvetti M.; Agresti C.
Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS)
2017 Abbracchio, Mp; Agresti, C; Antel, J; BaronVan Evercooren, A; Bresciani, A; Eberini, I; Goebels, N; Kuhlmann, T; Oumesmar, Bn; Olla, S; Salvetti, M; Zipp, F; Baranzini, S; Martino, G
Overexpression of the Cytokine BAFF and Autoimmunity Risk
2017 Steri, M.; Orru, V.; Idda, M. L.; Pitzalis, M.; Pala, M.; Zara, I.; Sidore, C.; Faa, V.; Floris, M.; Deiana, M.; Asunis, I.; Porcu, E.; Mulas, A.; Piras, M. G.; Lobina, M.; Lai, S.; Marongiu, M.; Serra, V.; Marongiu, M.; Sole, G.; Busonero, F.; Maschio, A.; Cusano, R.; Cuccuru, G.; Deidda, F.; Poddie, F.; Farina, G.; Dei, M.; Virdis, F.; Olla, S.; Satta, M. A.; Pani, M.; Delitala, A.; Cocco, E.; Frau, J.; Coghe, G.; Lorefice, L.; Fenu, G.; Ferrigno, P.; Ban, M.; Barizzone, N.; Leone, M.; Guerini, F. R.; Piga, M.; Firinu, D.; Kockum, I.; Bomfim, I. Lima; Olsson, T.; Alfredsson, L.; Suarez, A.; Carreira, P. E.; CastilloPalma, M. J.; Marcus, J. H.; Congia, M.; Angius, A.; Melis, M.; Gonzalez, A.; Riquelme, M. E. A.; da Silva, B. M.; Marchini, M.; Danieli, M. G.; Del Giacco, S.; Mathieu, A.; Pani, A.; Montgomery, S. B.; Rosati, G.; Hillert, J.; Sawcer, S.; D'Alfonso, S.; Todd, J. A.; Novembre, J.; Abecasis, G. R.; Whalen, M. B.; Marrosu, M. G.; Meloni, A.; Sanna, S.; Gorospe, M.; Schlessinger, D.; Fiorillo, E.; Zoledziewska, M.; Cucca, F.
An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes
2014 Gissi, Andrea; Gadaleta, Domenico; Floris, Matte; Olla, Stefania; Carotti, Angelo; Novellino, Ettore; Benfenati, Emilio; Nicolotti, Orazio
An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes
2014 Gissi A;Gadaleta D;Floris M;Olla S;Carotti A;Novellino E;Benfenati E;Nicolotti O;
MMsDusty: an Alternative InChI-Based Tool to Minimize Chemical Redundancy
2013 Fanton, M; Floris, M; Cristiani, A; Olla, S; Medda, R; Sabbadin, D; Bulfone, A; Moro, S
Overlapping syndromes in laminopathies: A meta-analysis of the reported literature
2013 Carboni, N; Politano, L; Floris, M; Mateddu, A; Solla, E; Olla, S; Maggi, L; Maioli, Ma; Piras, R; Cocco, E; Marrosu, G; Marrosu, Mg
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors
2009 Olla, S; Manetti, F; Crespan, E; Maga, G; Angelucci, A; Schenone, S; Bologna, M; Botta, M
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies
2008 La Regina, G; D'Auria, Fd; Tafi, A; Piscitelli, F; Olla, S; Caporuscio, F; Nencioni, L; Cirilli, R; La Torre, F; De Melo, Nr; Kelly, Sl; Lamb, Dc; Artico, M; Botta, M; Palamara, At; Silvestri, R
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes | 1-gen-2023 | Stefania Olla ; Chiara Siguri ; Antonella Fais ; Benedetta Era ; Massimo Claudio Fantini ; Amalia Di Petrillo | |
| Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes | 1-gen-2023 | Colombo, Eleonora; Olla, Stefania; Minnelli, Cristina; Formato, Alessia; Veroni, Caterina; Corbisiero, Silvia; Pericolo, Mattia; Siguri, Chiara; Mobbili, Giovanna; Agresti, Cristina; Seneci, Pierfausto | |
| Combining human genetics of multiple sclerosis with oxidative stress phenotype for drug repositioning | 1-gen-2021 | Olla, Stefania; Steri, Maristella; Formato, Alessia; Whalen, Michael B.; Corbisiero, Silvia; Agresti, Cristina | |
| A Sardinian founder mutation in glycoprotein Ib platelet subunit beta(GP1BB) that impacts thrombocytopenia | 1-gen-2020 | Busonero, Fabio; Steri, Maristella; Orru, Valeria; Sole, Gabriella; Olla, Stefania; Marongiu, Michele; Maschio, Andrea; Sidore, Carlo; Lai, Sandra; Mulas, Antonella; Zoledziewska, Magdalena; Floris, Matteo; Pala, Mauro; Forabosco, Paola; Asunis, Isadora; Pitzalis, Maristella; Deidda, Francesca; Masala, Marco; Caria, Cristian Antonio; Barella, Susanna; Abecasis, Goncalo R.; Schlessinger, David; Sanna, Serena; Fiorillo, Edoardo; Cucca, Francesco | |
| Complex genetic signatures in immune cells underlie autoimmunity and inform therapy | 1-gen-2020 | Orrù, V; Steri, M; Sidore, C; Marongiu, M; Serra, V; Olla, S; Sole, G; Lai, S; Dei, M; Mulas, A; Virdis, F; Piras, Mg; Lobina, M; Marongiu, M; Pitzalis, M; Deidda, F; Loizedda, A; Onano, S; Zoledziewska, M; Sawcer, S; Devoto, M; Gorospe, M; Abecasis, Gr; Floris, M; Pala, M; Schlessinger, D; Fiorillo, E; Cucca, F | |
| Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone | 1-gen-2020 | Agresti, Cristina; Mechelli, Rosella; Olla, Stefania; Veroni, Caterina; Eleuteri, Cecilia; Ristori, Giovanni; Salvetti, Marco | |
| Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP | 1-gen-2019 | Angius, Andrea; Uva, Paolo; Oppo, Manuela; Persico, Ivana; Onano, Stefano; Olla, Stefania; Pes, Valentina; Perria, Chiara; Cuccuru, Gianmauro; Atzeni, Rossano; Serra, Gigliola; Cucca, Francesco; Sotgiu, Stefano; Hennekam Raoul, C; Crisponi, Laura | |
| Genetic-Driven Druggable Target Identification and Validation | 1-gen-2018 | Floris, Matteo; Olla, Stefania; Schlessinger, David; Cucca, Francesco | |
| A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials | 1-gen-2017 | Eleuteri C.; Olla S.; Veroni C.; Umeton R.; Mechelli R.; Romano S.; Buscarinu M.C.; Ferrari F.; Calo G.; Ristori G.; Salvetti M.; Agresti C. | |
| Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS) | 1-gen-2017 | Abbracchio, Mp; Agresti, C; Antel, J; BaronVan Evercooren, A; Bresciani, A; Eberini, I; Goebels, N; Kuhlmann, T; Oumesmar, Bn; Olla, S; Salvetti, M; Zipp, F; Baranzini, S; Martino, G | |
| Overexpression of the Cytokine BAFF and Autoimmunity Risk | 1-gen-2017 | Steri, M.; Orru, V.; Idda, M. L.; Pitzalis, M.; Pala, M.; Zara, I.; Sidore, C.; Faa, V.; Floris, M.; Deiana, M.; Asunis, I.; Porcu, E.; Mulas, A.; Piras, M. G.; Lobina, M.; Lai, S.; Marongiu, M.; Serra, V.; Marongiu, M.; Sole, G.; Busonero, F.; Maschio, A.; Cusano, R.; Cuccuru, G.; Deidda, F.; Poddie, F.; Farina, G.; Dei, M.; Virdis, F.; Olla, S.; Satta, M. A.; Pani, M.; Delitala, A.; Cocco, E.; Frau, J.; Coghe, G.; Lorefice, L.; Fenu, G.; Ferrigno, P.; Ban, M.; Barizzone, N.; Leone, M.; Guerini, F. R.; Piga, M.; Firinu, D.; Kockum, I.; Bomfim, I. Lima; Olsson, T.; Alfredsson, L.; Suarez, A.; Carreira, P. E.; CastilloPalma, M. J.; Marcus, J. H.; Congia, M.; Angius, A.; Melis, M.; Gonzalez, A.; Riquelme, M. E. A.; da Silva, B. M.; Marchini, M.; Danieli, M. G.; Del Giacco, S.; Mathieu, A.; Pani, A.; Montgomery, S. B.; Rosati, G.; Hillert, J.; Sawcer, S.; D'Alfonso, S.; Todd, J. A.; Novembre, J.; Abecasis, G. R.; Whalen, M. B.; Marrosu, M. G.; Meloni, A.; Sanna, S.; Gorospe, M.; Schlessinger, D.; Fiorillo, E.; Zoledziewska, M.; Cucca, F. | |
| An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes | 1-gen-2014 | Gissi, Andrea; Gadaleta, Domenico; Floris, Matte; Olla, Stefania; Carotti, Angelo; Novellino, Ettore; Benfenati, Emilio; Nicolotti, Orazio | |
| An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes | 1-gen-2014 | Gissi A;Gadaleta D;Floris M;Olla S;Carotti A;Novellino E;Benfenati E;Nicolotti O; | |
| MMsDusty: an Alternative InChI-Based Tool to Minimize Chemical Redundancy | 1-gen-2013 | Fanton, M; Floris, M; Cristiani, A; Olla, S; Medda, R; Sabbadin, D; Bulfone, A; Moro, S | |
| Overlapping syndromes in laminopathies: A meta-analysis of the reported literature | 1-gen-2013 | Carboni, N; Politano, L; Floris, M; Mateddu, A; Solla, E; Olla, S; Maggi, L; Maioli, Ma; Piras, R; Cocco, E; Marrosu, G; Marrosu, Mg | |
| Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors | 1-gen-2009 | Olla, S; Manetti, F; Crespan, E; Maga, G; Angelucci, A; Schenone, S; Bologna, M; Botta, M | |
| 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies | 1-gen-2008 | La Regina, G; D'Auria, Fd; Tafi, A; Piscitelli, F; Olla, S; Caporuscio, F; Nencioni, L; Cirilli, R; La Torre, F; De Melo, Nr; Kelly, Sl; Lamb, Dc; Artico, M; Botta, M; Palamara, At; Silvestri, R |